[ad_1]
Hofseth Biocare, based in Ålesund, reported pre-tax and after-tax profit of minus 20.3 million NOK in the third quarter of 2018, compared to 12.0 million NOK in the same period last year.
Earnings per share was minus 0.08 kronor, compared with less than 0.05 kroner at the same crossroads last year.
Operating profit (EBIT) was established at minus 20.2 million NOK, against 11.3 million NOK last year.
EBITDA (operating profit before depreciation and amortization) was established at NOK 14.7 million, compared to NOK 6.3 million.
Operating income amounted to NOK 16.9 million compared to NOK 27.9 million in the third quarter of 2017.
Report here.
[ad_2]
Source link
